drugset / Trial / NCT05222269
[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients
NaSingle-groupOpen-labelDiagnostic
Summary
This will be an open, single-arm, international, multicentre, phase II imaging study to assess the predictive value of \[68Ga\]Ga PentixaFor PET imaging in primary and isolated secondary central nervous system lymphoma (CNSL) patients scheduled to undergo induction chemotherapy.
Timeline
- Start
- 2022-10-05
- Primary completion
- 2023-01-25
- Completion
- 2023-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-Pentixafor | Peptide | 150 mbq | Intravenous |